Beam Therapeutics Inc.
BEAM
$15.23
-$1.23-7.47%
| Weiss Ratings | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.23 | |||
| Price History | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -30.21% | |||
| 30-Day Total Return | -49.75% | |||
| 60-Day Total Return | -43.54% | |||
| 90-Day Total Return | -35.16% | |||
| Year to Date Total Return | -38.10% | |||
| 1-Year Total Return | -47.33% | |||
| 2-Year Total Return | -48.29% | |||
| 3-Year Total Return | -75.48% | |||
| 5-Year Total Return | -8.17% | |||
| 52-Week High % Change | -53.30% | |||
| 52-Week Low % Change | 0.98% | |||
| Price | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $35.25 | |||
| 52-Week Low Price | $16.30 | |||
| 52-Week Low Price (Date) | Apr 03, 2025 | |||
| 52-Week High Price (Date) | Feb 18, 2025 | |||
| Valuation | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.34B | |||
| Enterprise Value | 645.78M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -4.58 | |||
| Earnings Per Share Growth | 139.79% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 21.46 | |||
| Price/Book (Q) | 1.82 | |||
| Enterprise Value/Revenue (TTM) | 10.17 | |||
| Price | $15.29 | |||
| Enterprise Value/EBITDA (TTM) | -1.64 | |||
| Enterprise Value/EBIT | -1.55 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 82.82M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 857 327 8775 | |||
| Address | 238 Main Street Cambridge, MA 02142 | |||
| Website | beamtx.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -654.25% | |||
| Profit Margin | -593.12% | |||
| Management Effectiveness | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -20.26% | |||
| Return on Equity | -- | |||
| Income Statement | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 63.52M | |||
| Total Revenue (TTM) | 63.52M | |||
| Revenue Per Share | $0.77 | |||
| Gross Profit (TTM) | -304.04M | |||
| EBITDA (TTM) | -393.64M | |||
| EBIT (TTM) | -415.57M | |||
| Net Income (TTM) | -376.74M | |||
| Net Income Avl. to Common (TTM) | -376.74M | |||
| Total Revenue Growth (Q YOY) | -90.49% | |||
| Earnings Growth (Q YOY) | -163.27% | |||
| EPS Diluted (TTM) | -4.58 | |||
| EPS Diluted Growth (Q YOY) | -163.44% | |||
| Balance Sheet | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 850.74M | |||
| Cash Per Share (Q) | $10.27 | |||
| Total Current Assets (Q) | 878.15M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 733.55M | |||
| Current Ratio (Q) | 4.823 | |||
| Book Value Per Share (Q) | $9.05 | |||
| Total Assets (Q) | 1.10B | |||
| Total Current Liabilities (Q) | 182.07M | |||
| Total Debt (Q) | 161.43M | |||
| Total Liabilities (Q) | 370.28M | |||
| Total Common Equity (Q) | 733.55M | |||
| Cash Flow | BEAM - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 185.01M | |||
| Cash from Financing (TTM) | 7.74M | |||
| Net Change in Cash (TTM) | -154.50M | |||
| Levered Free Cash Flow (TTM) | -156.04M | |||
| Cash from Operations (TTM) | -347.25M | |||
